about
Sulfated quaternary amine lipids: a new class of inverse charge zwitterlipids.Phospholipid-based self-assembled mesophase systems for light-activated drug delivery.Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems.A novel approach to enhance the mucoadhesion of lipid drug nanocarriers for improved drug delivery to the buccal mucosa.Generation of geometrically ordered lipid-based liquid-crystalline nanoparticles using biologically relevant enzymatic processing.Oil-loaded monolinolein-based particles with confined inverse discontinuous cubic structure (Fd3m).Self-assembled structures and pKa value of oleic acid in systems of biological relevance.Material transfer in cubosome-emulsion mixtures: effect of alkane chain length.Influence of the stabilizer concentration on the internal liquid crystalline order and the size of oil-loaded monolinolein-based dispersions.Selective deuteration for molecular insights into the digestion of medium chain triglycerides.Formation of highly organized nanostructures during the digestion of milk.Preparation of highly concentrated nanostructured dispersions of controlled size.Enzyme-Triggered Dissociation of a FRET-Based Protein Biosensor Monitored by Synchrotron SAXS.Self-coacervation of modular squid beak proteins - a comparative study.pH-Triggered nanostructural transformations in antimicrobial peptide/oleic acid self-assemblies.Structural Investigation of Bulk and Dispersed Inverse Lyotropic Hexagonal Liquid Crystalline Phases of Eicosapentaenoic Acid Monoglyceride.Direct monitoring of lipid transfer on exposure of citrem nanoparticles to an ethanol solution containing soybean phospholipids by combining synchrotron SAXS with microfluidics.Softwood Lignin Self-Assembly for Nanomaterial Design.Microfluidic Platform for the Continuous Production and Characterization of Multilamellar Vesicles: A Synchrotron Small-Angle X-ray Scattering (SAXS) Study.Microemulsions as Potential Carriers of Nisin: Effect of Composition on Structure and Efficacy.Understanding the Mechanism of Enzyme-Induced Formation of Lyotropic Liquid Crystalline Nanoparticles.Antimicrobial Peptide-Driven Colloidal Transformations in Liquid-Crystalline Nanocarriers.Immobilised lipase for in vitro lipolysis experiments.Self-assembly structure formation during the digestion of human breast milk.Structural characterization of self-assemblies of new omega-3 lipids: docosahexaenoic acid and docosapentaenoic acid monoglyceridesHow relevant are assembled equilibrium samples in understanding structure formation during lipid digestion?pH-responsive micelles based on caprylic acidFormation of drug nanocrystals under nanoconfinement afforded by liposomesCorrection: Formation of drug nanocrystals under nanoconfinement afforded by liposomesEnhanced Antimicrobial Activity and Structural Transitions of a Nanofibrillated Cellulose–Nisin Biocomposite SuspensionIn Situ Monitoring of Nanostructure Formation during the Digestion of MayonnaiseDisposition and crystallization of saturated fatty acid in mixed micelles of relevance to lipid digestionpH-driven colloidal transformations based on the vasoactive drug nicergolineColloidal Transformations in MS2 Virus Particles: Driven by pH, Influenced by Natural Organic MatterFrom Structure to Function: pH-Switchable Antimicrobial Nano-Self-AssembliesFormation of highly ordered liquid crystalline coatings - an in situ GISAXS studyTemperature triggering of kinetically trapped self-assemblies in citrem-phospholipid nanoparticlesHydrogen bond guidance and aromatic stacking drive liquid-liquid phase separation of intrinsically disordered histidine-rich peptidesInternal Lamellar and Inverse Hexagonal Liquid Crystalline Phases During the Digestion of Krill and Astaxanthin Oil-in-Water EmulsionspH-Responsive Nano-Self-Assemblies of the Anticancer Drug 2-Hydroxyoleic Acid
P50
Q34427044-3B18A7C6-6111-4432-8787-AECCB678B769Q35624867-6D2E1530-F0A5-4621-A09B-C2EE6B29B86CQ38383061-2B9E83FC-FD05-4B11-9B34-0748C0F8197BQ41608317-3182144C-779C-42EF-8AAC-2C942F197419Q41608561-2BDBEBED-7D30-4C74-9CCD-73BC4307E787Q41626498-7A80A15F-3F7A-4F24-A30F-3EB3157940BEQ43005424-BC9833AA-2FC1-4501-BB28-8211E0014B91Q43073661-86E71960-61F1-4584-8492-5E2F1D8FB36AQ43167419-559F03B5-366E-429C-A71B-87D73C09E153Q46704170-91A440C3-7AD7-44A6-8C38-954EB5CE8B7CQ46974949-9AE72E3C-7EF9-4A58-9B72-8342D6527000Q47221792-2C073689-20CB-48A3-9745-5D6F244EA36BQ47432427-4C47F0C4-0125-4EB5-87B5-F944581A130CQ47434611-0BF91B74-FAD6-4943-ABDF-A4B8C57710D5Q47695112-0DFA34C9-DD08-414E-9108-571E7C8EF8A1Q47840347-451898E2-A5EF-4A23-8C85-B5EA0B484C62Q47880072-3B961C23-CB92-4575-A758-88D68F52FE0BQ48124113-87AF5CD4-5F42-4789-8CC1-187AC47EF047Q48167237-E6A64B23-7BF8-48CE-8B41-3EBB9226F8B8Q51211364-1E2A3352-0D87-421E-85E7-8AF638B9BB10Q52660560-2D4515BD-22B4-47FF-BB1F-B2FB2C3DB563Q52674391-484F46A0-168C-41F0-8E64-42699F7AD655Q53625882-BEF4A6E6-A9DA-4E91-9E3C-4A4C3B6132A4Q53668721-F01CCC4C-6920-447F-8E4B-A3D80B592451Q56977165-88D87576-6B1E-4339-92B9-E22B05098B09Q57142120-99D36CCA-1215-42ED-AA58-F81E143DCBECQ57151561-C7CA5172-D328-4892-9944-E372E986D4D2Q58493073-5482FA24-22DE-4CBF-8C92-13769C155160Q59234206-BE7860AB-C271-4053-8A6A-C8C71B6F1B8DQ61881576-0EF62320-9EE9-4850-8250-62F25D563732Q61921761-E3E0ACDB-E389-4DF1-B90B-13CE6F704613Q61985514-F2A69600-C114-41F5-BCB7-4F1D64765455Q86022181-109492C6-9C83-419A-8109-8F429C0720DCQ89573576-750C54D3-D983-49CE-82D2-24E0710E575EQ90772382-DEED3297-B59A-42CD-9EB1-412414C74BDAQ91032873-1CAA24FA-25A0-41A9-BA36-37C74D38AC0EQ91484190-9008054F-C33B-4303-B6CA-A2F7BD5353BEQ91558615-FF6675AE-2A8B-4A52-805A-E6AD5F475618Q92191008-AC16A4A1-FA5B-4912-AED7-0964B027BAB8Q92439350-D781F4B1-BD2E-4976-9710-6960A9BA5B1B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefan Salentinig
@ast
Stefan Salentinig
@en
Stefan Salentinig
@es
Stefan Salentinig
@nl
Stefan Salentinig
@sl
type
label
Stefan Salentinig
@ast
Stefan Salentinig
@en
Stefan Salentinig
@es
Stefan Salentinig
@nl
Stefan Salentinig
@sl
prefLabel
Stefan Salentinig
@ast
Stefan Salentinig
@en
Stefan Salentinig
@es
Stefan Salentinig
@nl
Stefan Salentinig
@sl
P106
P21
P31
P496
0000-0002-7541-2734